Macular disease detection with a swept-source optical coherence tomography-based biometry device in patients scheduled for cataract surgery : Journal of Cataract & Refractive Surgery

Secondary Logo

Journal Logo

Article

Macular disease detection with a swept-source optical coherence tomography-based biometry device in patients scheduled for cataract surgery

Hirnschall, Nino MD, PhD; Leisser, Christoph MD; Radda, Stephan MD; Maedel, Sophie MD; Findl, Oliver MD, MBA*

Author Information
Journal of Cataract & Refractive Surgery 42(4):p 530-536, April 2016. | DOI: 10.1016/j.jcrs.2016.02.029

Abstract

Purpose 

To assess the sensitivity and specificity for detecting macular disease with a new optical biometry device with swept-source optical coherence tomography (SS-OCT) used before cataract surgery.

Setting 

Hanusch Hospital, Vienna, Austria.

Design 

Consecutive case series.

Methods 

This study included patients with or without macular disease. All patients were scanned using the new biometry device (IOLMaster 700), which allows a 1.0 mm central retinal scan using SS-OCT technology. Also, all eyes were assessed using a dedicated retinal OCT device (RTVue) on the same day. Two experienced examiners and 1 ophthalmology resident graded all scans individually. Sensitivity and specificity for detecting macular disease were assessed, as were the receiver operating characteristic curves.

Results 

Of the 125 eyes included, 5 were excluded from the analysis, 65 had a macular disease, and 55 were healthy. The sensitivity of the biometry device was moderate (between 42% and 68%), and the specificity was high (89% to 98%). Intraobserver reproducibility for assessing the biometry device was 88.3%.

Conclusions 

The biometry device with SS-OCT provided useful information concerning the macula, especially for intraretinal fluid and macular holes. However, it cannot replace a macular OCT device.

Financial Disclosure 

None of the authors has a financial or proprietary interest in any material or method mentioned.

© 2016 by Lippincott Williams & Wilkins, Inc.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid